Home
/
STRATA Skin Sciences, Inc.
/
Financials
/
Quarterly
STRATA Skin Sciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that STRATA Skin Sciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2013
Sep 30, 2013
$107.7K
Nov 8, 2013
Q2
2013
Jun 30, 2013
$144.4K
Aug 7, 2013
Q1
2013
Mar 31, 2013
$144.1K
Apr 30, 2013
Q3
2012
Sep 30, 2012
$69.1K
Nov 7, 2012
Q2
2012
Jun 30, 2012
$75.8K
Aug 7, 2012
Q1
2012
Mar 31, 2012
$11.3K
May 3, 2012
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$6.93M
Nov 14, 2025
Q2
2025
Jun 30, 2025
$7.66M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$6.81M
May 15, 2025
Q3
2025
Sep 30, 2024
$8.80M
Nov 14, 2025
Q2
2025
Jun 30, 2024
$8.44M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$6.75M
May 15, 2025
Q3
2024
Sep 30, 2023
$8.85M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$8.25M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$7.57M
May 15, 2024
Q3
2023
Sep 30, 2022
$9.41M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$9.11M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$7.04M
May 15, 2023
Q3
2022
Sep 30, 2021
$7.71M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$7.38M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$5.83M
May 11, 2022
Q3
2021
Sep 30, 2020
$5.61M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$4.03M
Aug 16, 2021
Q1
2021
Mar 31, 2020
$6.73M
May 13, 2021
Q3
2020
Sep 30, 2019
$7.48M
Nov 10, 2020
Q2
2020
Jun 30, 2019
$7.73M
Aug 12, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$7.48M
Nov 14, 2017
Q2
2017
Jun 30, 2017
$8.70M
Aug 11, 2017
Q1
2017
Mar 31, 2017
$7.27M
May 15, 2017
Q3
2017
Sep 30, 2016
$7.77M
Nov 14, 2017
Q2
2017
Jun 30, 2016
$7.74M
Aug 11, 2017
Q1
2017
Mar 31, 2016
$7.62M
May 15, 2017
Q3
2016
Sep 30, 2015
$8.32M
Nov 14, 2016
Q2
2016
Jun 30, 2015
$611.0K
Aug 12, 2016
Q1
2016
Mar 31, 2015
$81.0K
May 16, 2016
Q3
2015
Sep 30, 2014
$218.0K
Nov 16, 2015
Q2
2015
Jun 30, 2014
$225.0K
Aug 14, 2015
Q1
2015
Mar 31, 2014
$97.6K
May 14, 2015
Q3
2014
Sep 30, 2013
$107.7K
Nov 14, 2014
Q2
2014
Jun 30, 2013
$144.4K
Aug 14, 2014
Q1
2014
Mar 31, 2013
$144.1K
May 14, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.62M)
Nov 14, 2025
Q3
2025
Jun 30, 2025
($2.58M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($2.49M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($2.12M)
Nov 14, 2025
Q2
2025
Mar 31, 2025
($2.43M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($2.43M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.07M)
Nov 14, 2025
Q3
2025
Jun 30, 2024
($91.0K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($99.0K)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($3.37M)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($3.37M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($3.37M)
May 15, 2025
Q3
2024
Sep 30, 2023
($1.05M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($3.15M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($3.15M)
Aug 14, 2024
Q3
2024
Mar 31, 2023
($2.84M)
Nov 14, 2024
Q2
2024
Mar 31, 2023
($2.84M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($2.84M)
May 15, 2024
Q3
2023
Sep 30, 2022
($995.0K)
Nov 14, 2023
Q3
2023
Jun 30, 2022
($1.89M)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.17M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($2.22M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($2.31M)
Nov 14, 2025
Q3
2025
Mar 31, 2025
($1.71M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($2.02M)
May 15, 2025
Q3
2025
Sep 30, 2024
($1.61M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($486.0K)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($478.0K)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($2.89M)
May 15, 2025
Q3
2025
Mar 31, 2024
($2.89M)
Nov 14, 2025
Q3
2024
Sep 30, 2023
($615.0K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.96M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($2.59M)
May 15, 2024
Q3
2023
Sep 30, 2022
($786.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.69M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($2.30M)
May 15, 2023
Q3
2022
Sep 30, 2021
($465.0K)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($923.0K)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($2.39M)
May 11, 2022
Q3
2021
Sep 30, 2020
($1.16M)
Nov 12, 2021